Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.64302981 |
2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.64302981 |
3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.04827393 |
4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.33377031 |
5 | negative regulation of cell killing (GO:0031342) | 4.33377031 |
6 | alpha-linolenic acid metabolic process (GO:0036109) | 4.25524260 |
7 | response to muramyl dipeptide (GO:0032495) | 4.15407218 |
8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.04171643 |
9 | detection of bacterium (GO:0016045) | 3.87115105 |
10 | valine metabolic process (GO:0006573) | 3.86076300 |
11 | complement activation, alternative pathway (GO:0006957) | 3.78742027 |
12 | detection of other organism (GO:0098543) | 3.76731400 |
13 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.74668837 |
14 | L-phenylalanine catabolic process (GO:0006559) | 3.74668837 |
15 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.67580360 |
16 | thymic T cell selection (GO:0045061) | 3.66663786 |
17 | germinal center formation (GO:0002467) | 3.64913559 |
18 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.64229215 |
19 | L-phenylalanine metabolic process (GO:0006558) | 3.63358536 |
20 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.63358536 |
21 | urea metabolic process (GO:0019627) | 3.61884203 |
22 | urea cycle (GO:0000050) | 3.61884203 |
23 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.58669197 |
24 | kynurenine metabolic process (GO:0070189) | 3.58381081 |
25 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.56923300 |
26 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.51569432 |
27 | negative regulation of fibrinolysis (GO:0051918) | 3.51289593 |
28 | aromatic amino acid family catabolic process (GO:0009074) | 3.50849253 |
29 | B cell receptor signaling pathway (GO:0050853) | 3.48229769 |
30 | tolerance induction (GO:0002507) | 3.45275112 |
31 | indole-containing compound catabolic process (GO:0042436) | 3.43800464 |
32 | indolalkylamine catabolic process (GO:0046218) | 3.43800464 |
33 | tryptophan catabolic process (GO:0006569) | 3.43800464 |
34 | positive regulation of B cell differentiation (GO:0045579) | 3.40523487 |
35 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.39630760 |
36 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.39630760 |
37 | modulation by symbiont of host immune response (GO:0052553) | 3.39630760 |
38 | positive regulation by symbiont of host defense response (GO:0052509) | 3.39630760 |
39 | modulation by symbiont of host defense response (GO:0052031) | 3.39630760 |
40 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.39630760 |
41 | protein carboxylation (GO:0018214) | 3.36397729 |
42 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.36397729 |
43 | lysine metabolic process (GO:0006553) | 3.36252063 |
44 | lysine catabolic process (GO:0006554) | 3.36252063 |
45 | tryptophan metabolic process (GO:0006568) | 3.32840294 |
46 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.31767806 |
47 | sulfur amino acid catabolic process (GO:0000098) | 3.31474102 |
48 | regulation of protein activation cascade (GO:2000257) | 3.29098372 |
49 | regulation of triglyceride catabolic process (GO:0010896) | 3.26848902 |
50 | regulation of gamma-delta T cell activation (GO:0046643) | 3.24838266 |
51 | phospholipid homeostasis (GO:0055091) | 3.24632390 |
52 | T cell selection (GO:0045058) | 3.24130112 |
53 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.22039935 |
54 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.20921953 |
55 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.20192155 |
56 | response to peptidoglycan (GO:0032494) | 3.18021851 |
57 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.16445018 |
58 | nitrogen cycle metabolic process (GO:0071941) | 3.16321026 |
59 | regulation of cholesterol homeostasis (GO:2000188) | 3.16246636 |
60 | response to interleukin-15 (GO:0070672) | 3.14728515 |
61 | leukocyte aggregation (GO:0070486) | 3.14431420 |
62 | cysteine metabolic process (GO:0006534) | 3.13196480 |
63 | NIK/NF-kappaB signaling (GO:0038061) | 3.13087786 |
64 | negative regulation of cholesterol transport (GO:0032375) | 3.12121153 |
65 | negative regulation of sterol transport (GO:0032372) | 3.12121153 |
66 | regulation of complement activation (GO:0030449) | 3.11612103 |
67 | 2-oxoglutarate metabolic process (GO:0006103) | 3.11588042 |
68 | B cell homeostasis (GO:0001782) | 3.10163960 |
69 | bile acid biosynthetic process (GO:0006699) | 3.06383242 |
70 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.03703014 |
71 | high-density lipoprotein particle remodeling (GO:0034375) | 3.03316628 |
72 | low-density lipoprotein particle clearance (GO:0034383) | 3.02473968 |
73 | plasma lipoprotein particle clearance (GO:0034381) | 3.01925294 |
74 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.01692407 |
75 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.00708213 |
76 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.00686962 |
77 | regulation of cholesterol storage (GO:0010885) | 3.00336769 |
78 | regulation of fibrinolysis (GO:0051917) | 2.99932494 |
79 | positive regulation of lipid catabolic process (GO:0050996) | 2.98850366 |
80 | glyoxylate metabolic process (GO:0046487) | 2.97041735 |
81 | positive regulation of histone deacetylation (GO:0031065) | 2.94691823 |
82 | positive T cell selection (GO:0043368) | 2.91972507 |
83 | embryonic process involved in female pregnancy (GO:0060136) | 2.89137871 |
84 | phospholipid efflux (GO:0033700) | 2.88712344 |
85 | detection of external biotic stimulus (GO:0098581) | 2.88597960 |
86 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.88417646 |
87 | plasma lipoprotein particle assembly (GO:0034377) | 2.86822210 |
88 | macrophage activation involved in immune response (GO:0002281) | 2.85615412 |
89 | oxaloacetate metabolic process (GO:0006107) | 2.85135830 |
90 | tricarboxylic acid metabolic process (GO:0072350) | 2.84085703 |
91 | negative regulation of T cell mediated immunity (GO:0002710) | 2.82866157 |
92 | response to laminar fluid shear stress (GO:0034616) | 2.81251308 |
93 | protein-lipid complex assembly (GO:0065005) | 2.79411079 |
94 | reverse cholesterol transport (GO:0043691) | 2.78643243 |
95 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.77894167 |
96 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.77894167 |
97 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.77370000 |
98 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.75181554 |
99 | ethanol oxidation (GO:0006069) | 2.73786507 |
100 | histone H3-K36 demethylation (GO:0070544) | 2.73357995 |
101 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.73287358 |
102 | pentose-phosphate shunt (GO:0006098) | 2.72115267 |
103 | cellular response to interleukin-15 (GO:0071350) | 2.72072068 |
104 | acute-phase response (GO:0006953) | 2.71114168 |
105 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.70901197 |
106 | response to type I interferon (GO:0034340) | 2.70708630 |
107 | regulation of necroptotic process (GO:0060544) | 2.70445065 |
108 | response to host (GO:0075136) | 2.69209913 |
109 | response to host defenses (GO:0052200) | 2.69209913 |
110 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.69209913 |
111 | cellular response to type I interferon (GO:0071357) | 2.68407161 |
112 | type I interferon signaling pathway (GO:0060337) | 2.68407161 |
113 | pinocytosis (GO:0006907) | 2.67103066 |
114 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.67069788 |
115 | regulation of ARF protein signal transduction (GO:0032012) | 2.66726820 |
116 | bile acid metabolic process (GO:0008206) | 2.66605835 |
117 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.65887975 |
118 | modulation by symbiont of host cellular process (GO:0044068) | 2.65041782 |
119 | plasma lipoprotein particle remodeling (GO:0034369) | 2.62908947 |
120 | protein-lipid complex remodeling (GO:0034368) | 2.62908947 |
121 | macromolecular complex remodeling (GO:0034367) | 2.62908947 |
122 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.62107349 |
123 | Peyers patch development (GO:0048541) | 2.62020984 |
124 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.62020984 |
125 | complement activation, classical pathway (GO:0006958) | 2.61999528 |
126 | homocysteine metabolic process (GO:0050667) | 2.61521534 |
127 | amino-acid betaine metabolic process (GO:0006577) | 2.61235531 |
128 | activation of JUN kinase activity (GO:0007257) | 2.60534522 |
129 | complement activation (GO:0006956) | 2.57671422 |
130 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.57618204 |
131 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.57592177 |
132 | regulation of humoral immune response (GO:0002920) | 2.57002723 |
133 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.56267787 |
134 | lymphocyte homeostasis (GO:0002260) | 2.55695171 |
135 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.55250653 |
136 | acylglycerol homeostasis (GO:0055090) | 2.54502462 |
137 | triglyceride homeostasis (GO:0070328) | 2.54502462 |
138 | activation of MAPKKK activity (GO:0000185) | 2.54067113 |
139 | regulation of B cell differentiation (GO:0045577) | 2.52642442 |
140 | cellular modified amino acid catabolic process (GO:0042219) | 2.52365490 |
141 | positive thymic T cell selection (GO:0045059) | 2.51985433 |
142 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.51625093 |
143 | T cell migration (GO:0072678) | 2.50889313 |
144 | negative regulation of interleukin-12 production (GO:0032695) | 2.50004044 |
145 | negative regulation of lipid transport (GO:0032369) | 2.49982903 |
146 | positive regulation of fatty acid oxidation (GO:0046321) | 2.49788085 |
147 | negative regulation of myotube differentiation (GO:0010832) | 2.49624735 |
148 | cytolysis (GO:0019835) | 2.49581411 |
149 | detection of biotic stimulus (GO:0009595) | 2.48863957 |
150 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.48556178 |
151 | modulation by virus of host process (GO:0019054) | 2.48213398 |
152 | cholesterol efflux (GO:0033344) | 2.48032390 |
153 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.46852801 |
154 | NADPH regeneration (GO:0006740) | 2.46071325 |
155 | regulation of leukocyte degranulation (GO:0043300) | 2.45824519 |
156 | negative thymic T cell selection (GO:0045060) | 2.45729090 |
157 | regulation of integrin activation (GO:0033623) | 2.44064098 |
158 | positive regulation of granulocyte differentiation (GO:0030854) | 2.43491746 |
159 | serine family amino acid catabolic process (GO:0009071) | 2.42616567 |
160 | negative regulation of innate immune response (GO:0045824) | 2.42469596 |
161 | plasma lipoprotein particle organization (GO:0071827) | 2.41788726 |
162 | T cell homeostasis (GO:0043029) | 2.41446282 |
163 | negative regulation of phagocytosis (GO:0050765) | 2.40653700 |
164 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.40637143 |
165 | response to host immune response (GO:0052572) | 2.40404063 |
166 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.40404063 |
167 | protein-lipid complex subunit organization (GO:0071825) | 2.40390875 |
168 | signal complex assembly (GO:0007172) | 2.39924401 |
169 | mannose metabolic process (GO:0006013) | 2.39245030 |
170 | mature B cell differentiation involved in immune response (GO:0002313) | 2.39122523 |
171 | negative regulation of cell size (GO:0045792) | 2.37989706 |
172 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.37981554 |
173 | positive regulation of humoral immune response (GO:0002922) | 2.37935965 |
174 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.36969154 |
175 | negative T cell selection (GO:0043383) | 2.36349486 |
176 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.34827557 |
177 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.34293620 |
178 | neutrophil activation involved in immune response (GO:0002283) | 2.32449221 |
179 | regulation of ARF GTPase activity (GO:0032312) | 2.32262230 |
180 | stress fiber assembly (GO:0043149) | 2.31505652 |
181 | negative regulation of necroptotic process (GO:0060546) | 2.30916757 |
182 | positive regulation of Rap GTPase activity (GO:0032854) | 2.29810401 |
183 | immunoglobulin mediated immune response (GO:0016064) | 2.29496072 |
184 | leukocyte homeostasis (GO:0001776) | 2.29422325 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.38263160 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.86433801 |
3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.85313676 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.75213298 |
5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.63561495 |
6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.63137633 |
7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.97957833 |
8 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.91353122 |
9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.83494452 |
10 | MYC_22102868_ChIP-Seq_BL_Human | 2.80017516 |
11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.78920431 |
12 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.59030412 |
13 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.57289864 |
14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.50408694 |
15 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.41090225 |
16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.36968625 |
17 | GATA1_22025678_ChIP-Seq_K562_Human | 2.31396230 |
18 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.28619669 |
19 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.22524089 |
20 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.22433678 |
21 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.21074754 |
22 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.19713795 |
23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.18778397 |
24 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.17498521 |
25 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.16349541 |
26 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.11391131 |
27 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.10836003 |
28 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.07884458 |
29 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.02620248 |
30 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.99199325 |
31 | MAF_26560356_Chip-Seq_TH1_Human | 1.97659655 |
32 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.95316325 |
33 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.91943421 |
34 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.90127223 |
35 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.87361918 |
36 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.80813934 |
37 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.78902948 |
38 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72351663 |
39 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.72306402 |
40 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.70040568 |
41 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.65553263 |
42 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.65189025 |
43 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.65131495 |
44 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.64751655 |
45 | MYB_26560356_Chip-Seq_TH2_Human | 1.64221005 |
46 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.60304551 |
47 | MYB_26560356_Chip-Seq_TH1_Human | 1.56163926 |
48 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.54715195 |
49 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.52794733 |
50 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.52695931 |
51 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.51659299 |
52 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.51579728 |
53 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.50166279 |
54 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.49172824 |
55 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.47372846 |
56 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.47207345 |
57 | KDM2B_26808549_Chip-Seq_K562_Human | 1.46276769 |
58 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.45190543 |
59 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.45120038 |
60 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.44657368 |
61 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.40720894 |
62 | SPI1_23127762_ChIP-Seq_K562_Human | 1.39556341 |
63 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.38114560 |
64 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.37190989 |
65 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.32967845 |
66 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.31467199 |
67 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.30903394 |
68 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.30331941 |
69 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.28755313 |
70 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.28664748 |
71 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28618149 |
72 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.28335769 |
73 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.27851230 |
74 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.26061934 |
75 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.25409060 |
76 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.24725663 |
77 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23412960 |
78 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.23001092 |
79 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.22927362 |
80 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.20436026 |
81 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.20417302 |
82 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.20263108 |
83 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.18604763 |
84 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.18107284 |
85 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.18104620 |
86 | MAF_26560356_Chip-Seq_TH2_Human | 1.17334586 |
87 | P68_20966046_ChIP-Seq_HELA_Human | 1.16819388 |
88 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.16421678 |
89 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.16314473 |
90 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.13209596 |
91 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.12213257 |
92 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.11269582 |
93 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10310768 |
94 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10184420 |
95 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.09945534 |
96 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.08145236 |
97 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.07686665 |
98 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.07535439 |
99 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.06469929 |
100 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.05392458 |
101 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.05051372 |
102 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.04958301 |
103 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03574714 |
104 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.02346241 |
105 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01826030 |
106 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01768954 |
107 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01001884 |
108 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00640160 |
109 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.00549148 |
110 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.00303644 |
111 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.00242531 |
112 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98808372 |
113 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.98576871 |
114 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.98437014 |
115 | GATA1_19941826_ChIP-Seq_K562_Human | 0.98272797 |
116 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.96968736 |
117 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.96907911 |
118 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.96873720 |
119 | GATA2_19941826_ChIP-Seq_K562_Human | 0.96547353 |
120 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94719496 |
121 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93056598 |
122 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92804159 |
123 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.91933871 |
124 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.91903068 |
125 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.90873737 |
126 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90634408 |
127 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.89943636 |
128 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89728225 |
129 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.88698261 |
130 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.87856551 |
131 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.85945394 |
132 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81956992 |
133 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.81395956 |
134 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.79820296 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 4.08165807 |
2 | MP0005360_urolithiasis | 3.89248447 |
3 | MP0005365_abnormal_bile_salt | 3.42184483 |
4 | MP0005085_abnormal_gallbladder_physiolo | 2.89820176 |
5 | MP0009840_abnormal_foam_cell | 2.48626073 |
6 | MP0001835_abnormal_antigen_presentation | 2.41633224 |
7 | MP0003191_abnormal_cellular_cholesterol | 2.38405638 |
8 | MP0010329_abnormal_lipoprotein_level | 2.35402510 |
9 | MP0003300_gastrointestinal_ulcer | 2.35087029 |
10 | MP0005451_abnormal_body_composition | 2.32782377 |
11 | MP0003252_abnormal_bile_duct | 2.29994201 |
12 | MP0003436_decreased_susceptibility_to | 2.29874036 |
13 | MP0008875_abnormal_xenobiotic_pharmacok | 2.25089923 |
14 | MP0003303_peritoneal_inflammation | 2.22229957 |
15 | MP0010234_abnormal_vibrissa_follicle | 2.18299341 |
16 | MP0000685_abnormal_immune_system | 2.05396632 |
17 | MP0008260_abnormal_autophagy | 1.97689598 |
18 | MP0005464_abnormal_platelet_physiology | 1.94115027 |
19 | MP0000609_abnormal_liver_physiology | 1.88162247 |
20 | MP0003828_pulmonary_edema | 1.86097652 |
21 | MP0003656_abnormal_erythrocyte_physiolo | 1.85138102 |
22 | MP0002138_abnormal_hepatobiliary_system | 1.81626609 |
23 | MP0009785_altered_susceptibility_to | 1.80333329 |
24 | MP0003705_abnormal_hypodermis_morpholog | 1.78951208 |
25 | MP0005083_abnormal_biliary_tract | 1.78437215 |
26 | MP0002796_impaired_skin_barrier | 1.73924346 |
27 | MP0001800_abnormal_humoral_immune | 1.73604122 |
28 | MP0003453_abnormal_keratinocyte_physiol | 1.72703165 |
29 | MP0002166_altered_tumor_susceptibility | 1.68761719 |
30 | MP0004381_abnormal_hair_follicle | 1.67953543 |
31 | MP0005025_abnormal_response_to | 1.65620019 |
32 | MP0005387_immune_system_phenotype | 1.63898343 |
33 | MP0001790_abnormal_immune_system | 1.63898343 |
34 | MP0005671_abnormal_response_to | 1.62793792 |
35 | MP0003091_abnormal_cell_migration | 1.61767113 |
36 | MP0002419_abnormal_innate_immunity | 1.60863967 |
37 | MP0005397_hematopoietic_system_phenotyp | 1.55992489 |
38 | MP0001545_abnormal_hematopoietic_system | 1.55992489 |
39 | MP0002452_abnormal_antigen_presenting | 1.53868980 |
40 | MP0003724_increased_susceptibility_to | 1.53120972 |
41 | MP0005058_abnormal_lysosome_morphology | 1.51343089 |
42 | MP0001666_abnormal_nutrient_absorption | 1.49777736 |
43 | MP0010352_gastrointestinal_tract_polyps | 1.48381973 |
44 | MP0002396_abnormal_hematopoietic_system | 1.48302693 |
45 | MP0005319_abnormal_enzyme/_coenzyme | 1.46107916 |
46 | MP0001849_ear_inflammation | 1.44514184 |
47 | MP0005000_abnormal_immune_tolerance | 1.43395947 |
48 | MP0004947_skin_inflammation | 1.43096615 |
49 | MP0002723_abnormal_immune_serum | 1.43095713 |
50 | MP0002009_preneoplasia | 1.41708956 |
51 | MP0010155_abnormal_intestine_physiology | 1.39389864 |
52 | MP0002420_abnormal_adaptive_immunity | 1.39051628 |
53 | MP0001819_abnormal_immune_cell | 1.38626297 |
54 | MP0002398_abnormal_bone_marrow | 1.38169327 |
55 | MP0009278_abnormal_bone_marrow | 1.37508628 |
56 | MP0003763_abnormal_thymus_physiology | 1.36168566 |
57 | MP0008469_abnormal_protein_level | 1.34893295 |
58 | MP0003806_abnormal_nucleotide_metabolis | 1.34810078 |
59 | MP0001845_abnormal_inflammatory_respons | 1.34110658 |
60 | MP0009764_decreased_sensitivity_to | 1.32040734 |
61 | MP0005076_abnormal_cell_differentiation | 1.31594080 |
62 | MP0004185_abnormal_adipocyte_glucose | 1.29857550 |
63 | MP0005409_darkened_coat_color | 1.28646836 |
64 | MP0002118_abnormal_lipid_homeostasis | 1.28262561 |
65 | MP0006082_CNS_inflammation | 1.26634258 |
66 | MP0001348_abnormal_lacrimal_gland | 1.26140608 |
67 | MP0000689_abnormal_spleen_morphology | 1.24737271 |
68 | MP0003172_abnormal_lysosome_physiology | 1.24048168 |
69 | MP0005670_abnormal_white_adipose | 1.22499680 |
70 | MP0000716_abnormal_immune_system | 1.22364162 |
71 | MP0000598_abnormal_liver_morphology | 1.22238525 |
72 | MP0002998_abnormal_bone_remodeling | 1.22147700 |
73 | MP0001853_heart_inflammation | 1.21178129 |
74 | MP0001533_abnormal_skeleton_physiology | 1.21112700 |
75 | MP0003329_amyloid_beta_deposits | 1.20371849 |
76 | MP0004130_abnormal_muscle_cell | 1.20354310 |
77 | MP0004808_abnormal_hematopoietic_stem | 1.19551599 |
78 | MP0004264_abnormal_extraembryonic_tissu | 1.18875709 |
79 | MP0002722_abnormal_immune_system | 1.18399155 |
80 | MP0002006_tumorigenesis | 1.18232328 |
81 | MP0002405_respiratory_system_inflammati | 1.15218547 |
82 | MP0009763_increased_sensitivity_to | 1.13975049 |
83 | MP0005332_abnormal_amino_acid | 1.13873075 |
84 | MP0001851_eye_inflammation | 1.13574412 |
85 | MP0003566_abnormal_cell_adhesion | 1.13369955 |
86 | MP0006054_spinal_hemorrhage | 1.12701789 |
87 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.10768494 |
88 | MP0002429_abnormal_blood_cell | 1.10534015 |
89 | MP0001873_stomach_inflammation | 1.09989321 |
90 | MP0005501_abnormal_skin_physiology | 1.09751519 |
91 | MP0009643_abnormal_urine_homeostasis | 1.08005448 |
92 | MP0000604_amyloidosis | 1.05977444 |
93 | MP0001216_abnormal_epidermal_layer | 1.05423369 |
94 | MP0002148_abnormal_hypersensitivity_rea | 1.01199645 |
95 | MP0009931_abnormal_skin_appearance | 0.98880742 |
96 | MP0004510_myositis | 0.97446803 |
97 | MP0000733_abnormal_muscle_development | 0.97026133 |
98 | MP0005310_abnormal_salivary_gland | 0.96365246 |
99 | MP0005666_abnormal_adipose_tissue | 0.94859343 |
100 | MP0002060_abnormal_skin_morphology | 0.94409159 |
101 | MP0005023_abnormal_wound_healing | 0.93142274 |
102 | MP0008004_abnormal_stomach_pH | 0.92906569 |
103 | MP0000579_abnormal_nail_morphology | 0.90627651 |
104 | MP0002877_abnormal_melanocyte_morpholog | 0.88027679 |
105 | MP0000465_gastrointestinal_hemorrhage | 0.87784905 |
106 | MP0000858_altered_metastatic_potential | 0.86607031 |
107 | MP0000678_abnormal_parathyroid_gland | 0.85690379 |
108 | MP0003075_altered_response_to | 0.85369991 |
109 | MP0003279_aneurysm | 0.84964624 |
110 | MP0000015_abnormal_ear_pigmentation | 0.84653818 |
111 | MP0000343_altered_response_to | 0.84514566 |
112 | MP0000703_abnormal_thymus_morphology | 0.84020714 |
113 | MP0005375_adipose_tissue_phenotype | 0.83347304 |
114 | MP0002933_joint_inflammation | 0.83112622 |
115 | MP0009333_abnormal_splenocyte_physiolog | 0.82922060 |
116 | MP0005275_abnormal_skin_tensile | 0.82765771 |
117 | MP0001764_abnormal_homeostasis | 0.82556858 |
118 | MP0005621_abnormal_cell_physiology | 0.81689929 |
119 | MP0002254_reproductive_system_inflammat | 0.81030776 |
120 | MP0010307_abnormal_tumor_latency | 0.79693585 |
121 | MP0003866_abnormal_defecation | 0.79400554 |
122 | MP0000490_abnormal_crypts_of | 0.79111888 |
123 | MP0002136_abnormal_kidney_physiology | 0.78771263 |
124 | MP0005390_skeleton_phenotype | 0.78739725 |
125 | MP0003045_fibrosis | 0.78604932 |
126 | MP0009765_abnormal_xenobiotic_induced | 0.77935276 |
127 | MP0009115_abnormal_fat_cell | 0.77707089 |
128 | MP0000569_abnormal_digit_pigmentation | 0.77489498 |
129 | MP0005334_abnormal_fat_pad | 0.77479369 |
130 | MP0003186_abnormal_redox_activity | 0.77323791 |
131 | MP0005166_decreased_susceptibility_to | 0.77107724 |
132 | MP0001915_intracranial_hemorrhage | 0.73981915 |
133 | MP0009642_abnormal_blood_homeostasis | 0.73405017 |
134 | MP0008961_abnormal_basal_metabolism | 0.73342197 |
135 | MP0002971_abnormal_brown_adipose | 0.73213957 |
136 | MP0003183_abnormal_peptide_metabolism | 0.72925798 |
137 | MP0003448_altered_tumor_morphology | 0.72016745 |
138 | MP0002970_abnormal_white_adipose | 0.71665500 |
139 | MP0003690_abnormal_glial_cell | 0.71343531 |
140 | MP0000767_abnormal_smooth_muscle | 0.68583157 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 4.37252033 |
2 | Increased IgE level (HP:0003212) | 3.80032189 |
3 | Complement deficiency (HP:0004431) | 3.71682103 |
4 | Xanthomatosis (HP:0000991) | 3.56055980 |
5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.52699818 |
6 | Intrahepatic cholestasis (HP:0001406) | 3.33293267 |
7 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.32494092 |
8 | Hypobetalipoproteinemia (HP:0003563) | 3.26743231 |
9 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.08685826 |
10 | Abnormality of the common coagulation pathway (HP:0010990) | 3.02324342 |
11 | Abnormality of nail color (HP:0100643) | 3.02170268 |
12 | Myocardial infarction (HP:0001658) | 2.98256696 |
13 | Hyperlipoproteinemia (HP:0010980) | 2.96300089 |
14 | Abnormality of complement system (HP:0005339) | 2.95662679 |
15 | Joint hemorrhage (HP:0005261) | 2.83534108 |
16 | Prolonged partial thromboplastin time (HP:0003645) | 2.83366911 |
17 | Mediastinal lymphadenopathy (HP:0100721) | 2.81726646 |
18 | Eczematoid dermatitis (HP:0000976) | 2.80078654 |
19 | Autoimmune thrombocytopenia (HP:0001973) | 2.79754439 |
20 | Gingival bleeding (HP:0000225) | 2.73991378 |
21 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.67747909 |
22 | Systemic lupus erythematosus (HP:0002725) | 2.65790910 |
23 | Recurrent viral infections (HP:0004429) | 2.60693341 |
24 | Abnormality of macrophages (HP:0004311) | 2.60673999 |
25 | Obstructive sleep apnea (HP:0002870) | 2.56188697 |
26 | Mitral stenosis (HP:0001718) | 2.55253319 |
27 | Esophageal varix (HP:0002040) | 2.52009134 |
28 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.49779554 |
29 | Periodontitis (HP:0000704) | 2.48086238 |
30 | Hyperammonemia (HP:0001987) | 2.46792746 |
31 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.45987728 |
32 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.45703856 |
33 | Hypolipoproteinemia (HP:0010981) | 2.44966557 |
34 | Panhypogammaglobulinemia (HP:0003139) | 2.44136265 |
35 | Gastrointestinal stroma tumor (HP:0100723) | 2.41469012 |
36 | Epidermoid cyst (HP:0200040) | 2.39142501 |
37 | Broad face (HP:0000283) | 2.38412309 |
38 | Ketosis (HP:0001946) | 2.37881094 |
39 | Exercise-induced myalgia (HP:0003738) | 2.37243937 |
40 | Recurrent fungal infections (HP:0002841) | 2.37026714 |
41 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.36752224 |
42 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.36458304 |
43 | Epistaxis (HP:0000421) | 2.34776698 |
44 | Spontaneous hematomas (HP:0007420) | 2.34073970 |
45 | Abnormality of the intrinsic pathway (HP:0010989) | 2.31599361 |
46 | Recurrent bacterial skin infections (HP:0005406) | 2.30592069 |
47 | Asymmetric septal hypertrophy (HP:0001670) | 2.30543951 |
48 | Interstitial pulmonary disease (HP:0006530) | 2.29395606 |
49 | Recurrent cutaneous fungal infections (HP:0011370) | 2.28051342 |
50 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.28051342 |
51 | Thrombocytosis (HP:0001894) | 2.26153468 |
52 | Gingivitis (HP:0000230) | 2.26083280 |
53 | Cellulitis (HP:0100658) | 2.24205803 |
54 | Hypoglycemic coma (HP:0001325) | 2.23934937 |
55 | Colitis (HP:0002583) | 2.23338506 |
56 | Emphysema (HP:0002097) | 2.23164592 |
57 | Hepatocellular carcinoma (HP:0001402) | 2.22432150 |
58 | Abnormal platelet function (HP:0011869) | 2.22407653 |
59 | Impaired platelet aggregation (HP:0003540) | 2.22407653 |
60 | Hypoplasia of the thymus (HP:0000778) | 2.22275988 |
61 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.21937863 |
62 | Hypercholesterolemia (HP:0003124) | 2.20184952 |
63 | Abnormal platelet volume (HP:0011876) | 2.20172303 |
64 | Distal lower limb amyotrophy (HP:0008944) | 2.19039978 |
65 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.17692132 |
66 | Recurrent bronchitis (HP:0002837) | 2.15805174 |
67 | Fat malabsorption (HP:0002630) | 2.15503106 |
68 | Gastrointestinal infarctions (HP:0005244) | 2.14819963 |
69 | Hypoalphalipoproteinemia (HP:0003233) | 2.14120651 |
70 | Recurrent abscess formation (HP:0002722) | 2.13514918 |
71 | Milia (HP:0001056) | 2.12648304 |
72 | Poikilocytosis (HP:0004447) | 2.12609521 |
73 | Hyperbilirubinemia (HP:0002904) | 2.12074962 |
74 | Acanthocytosis (HP:0001927) | 2.12059384 |
75 | Thick nail (HP:0001805) | 2.11598124 |
76 | Spastic diplegia (HP:0001264) | 2.09301798 |
77 | Increased mean platelet volume (HP:0011877) | 2.09170196 |
78 | Myositis (HP:0100614) | 2.08341970 |
79 | Abnormality of the fingertips (HP:0001211) | 2.08128487 |
80 | IgM deficiency (HP:0002850) | 2.07641176 |
81 | Thrombophlebitis (HP:0004418) | 2.07346109 |
82 | Pustule (HP:0200039) | 2.06989069 |
83 | Chronic otitis media (HP:0000389) | 2.06181175 |
84 | Arterial thrombosis (HP:0004420) | 2.05115395 |
85 | T lymphocytopenia (HP:0005403) | 2.03736937 |
86 | Supranuclear gaze palsy (HP:0000605) | 2.02694043 |
87 | Verrucae (HP:0200043) | 2.02341660 |
88 | Papilloma (HP:0012740) | 2.02341660 |
89 | Neurofibrillary tangles (HP:0002185) | 2.01248177 |
90 | Distal lower limb muscle weakness (HP:0009053) | 2.00793451 |
91 | Amyloidosis (HP:0011034) | 2.00305741 |
92 | Atrophic scars (HP:0001075) | 2.00069358 |
93 | Peritonitis (HP:0002586) | 1.99571231 |
94 | Spondylolisthesis (HP:0003302) | 1.98813083 |
95 | Dysostosis multiplex (HP:0000943) | 1.97474743 |
96 | Polycythemia (HP:0001901) | 1.96084811 |
97 | Gastrointestinal inflammation (HP:0004386) | 1.95600676 |
98 | Urticaria (HP:0001025) | 1.95600240 |
99 | Viral hepatitis (HP:0006562) | 1.95570659 |
100 | Combined immunodeficiency (HP:0005387) | 1.95558326 |
101 | Abnormality of T cell number (HP:0011839) | 1.94255418 |
102 | Chest pain (HP:0100749) | 1.93669014 |
103 | Orchitis (HP:0100796) | 1.93399463 |
104 | Prolonged bleeding time (HP:0003010) | 1.92274318 |
105 | Inflammation of the large intestine (HP:0002037) | 1.92250398 |
106 | Menorrhagia (HP:0000132) | 1.91946854 |
107 | Skin ulcer (HP:0200042) | 1.91465323 |
108 | Recurrent skin infections (HP:0001581) | 1.90970429 |
109 | Thin bony cortex (HP:0002753) | 1.90749165 |
110 | Abnormality of T cells (HP:0002843) | 1.90206131 |
111 | Chronic obstructive pulmonary disease (HP:0006510) | 1.89593915 |
112 | Obstructive lung disease (HP:0006536) | 1.89593915 |
113 | Nasal polyposis (HP:0100582) | 1.88834385 |
114 | Agammaglobulinemia (HP:0004432) | 1.88169521 |
115 | Neuronal loss in central nervous system (HP:0002529) | 1.86398450 |
116 | Osteomyelitis (HP:0002754) | 1.85586666 |
117 | Sepsis (HP:0100806) | 1.85466794 |
118 | Abnormality of T cell physiology (HP:0011840) | 1.85086753 |
119 | Abnormality of purine metabolism (HP:0004352) | 1.85066558 |
120 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.83983843 |
121 | Abnormality of nucleobase metabolism (HP:0010932) | 1.83418763 |
122 | Abnormal blistering of the skin (HP:0008066) | 1.82927704 |
123 | Late onset (HP:0003584) | 1.82022579 |
124 | Pulmonary infiltrates (HP:0002113) | 1.81726328 |
125 | Long palpebral fissure (HP:0000637) | 1.81600077 |
126 | Vasculitis (HP:0002633) | 1.81491155 |
127 | Loss of speech (HP:0002371) | 1.81216790 |
128 | Hemorrhage of the eye (HP:0011885) | 1.80949521 |
129 | Hyperacusis (HP:0010780) | 1.80680258 |
130 | Persistence of primary teeth (HP:0006335) | 1.80506230 |
131 | Protrusio acetabuli (HP:0003179) | 1.80376845 |
132 | Ketoacidosis (HP:0001993) | 1.80332203 |
133 | Abnormality of iron homeostasis (HP:0011031) | 1.80124444 |
134 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.80123174 |
135 | Vascular calcification (HP:0004934) | 1.79868833 |
136 | Abnormality of the nasal mucosa (HP:0000433) | 1.79554644 |
137 | Tetraparesis (HP:0002273) | 1.79255872 |
138 | Hepatitis (HP:0012115) | 1.79169913 |
139 | Dilatation of the ascending aorta (HP:0005111) | 1.79123683 |
140 | Cerebral aneurysm (HP:0004944) | 1.78896709 |
141 | Polygenic inheritance (HP:0010982) | 1.78583665 |
142 | Meningitis (HP:0001287) | 1.77962411 |
143 | Plantar hyperkeratosis (HP:0007556) | 1.77873491 |
144 | Vacuolated lymphocytes (HP:0001922) | 1.76825170 |
145 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.76541906 |
146 | Cholelithiasis (HP:0001081) | 1.76078200 |
147 | Fatigue (HP:0012378) | 1.74927037 |
148 | Aneurysm (HP:0002617) | 1.72565912 |
149 | Cerebral inclusion bodies (HP:0100314) | 1.71559450 |
150 | Distal upper limb amyotrophy (HP:0007149) | 1.70870218 |
151 | Upper limb amyotrophy (HP:0009129) | 1.70870218 |
152 | Stomatitis (HP:0010280) | 1.70279488 |
153 | Onycholysis (HP:0001806) | 1.69802683 |
154 | Slow saccadic eye movements (HP:0000514) | 1.68707723 |
155 | Optic neuritis (HP:0100653) | 1.68639644 |
156 | Retrobulbar optic neuritis (HP:0100654) | 1.68639644 |
157 | Restrictive lung disease (HP:0002091) | 1.68513706 |
158 | Increased variability in muscle fiber diameter (HP:0003557) | 1.68139873 |
159 | Hypergammaglobulinemia (HP:0010702) | 1.67893155 |
160 | Syringomyelia (HP:0003396) | 1.66611675 |
161 | Spinal cord lesions (HP:0100561) | 1.66611675 |
162 | Abnormality of the columella (HP:0009929) | 1.65052918 |
163 | Arterial tortuosity (HP:0005116) | 1.64882177 |
164 | Erythema (HP:0010783) | 1.64240467 |
165 | Increased cerebral lipofuscin (HP:0011813) | 1.64145135 |
166 | Hypertensive crisis (HP:0100735) | 1.63406765 |
167 | Keratoconjunctivitis sicca (HP:0001097) | 1.63030595 |
168 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.62935287 |
169 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.62192807 |
170 | Abnormality of the thoracic spine (HP:0100711) | 1.61322615 |
171 | Increased serum ferritin (HP:0003281) | 1.61036961 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PRPF4B | 4.56102443 |
2 | TRIB3 | 4.33753319 |
3 | ERN1 | 4.31611571 |
4 | MAP4K1 | 3.16262095 |
5 | SIK1 | 2.91735254 |
6 | PKN2 | 2.88129903 |
7 | MAP3K10 | 2.83763876 |
8 | EEF2K | 2.57047850 |
9 | SMG1 | 2.38355863 |
10 | RIPK4 | 2.26858982 |
11 | TYK2 | 2.26565165 |
12 | TAOK3 | 2.25029899 |
13 | FGFR4 | 2.24182697 |
14 | TBK1 | 2.02554174 |
15 | JAK3 | 1.84139318 |
16 | STK10 | 1.83463212 |
17 | PTK6 | 1.81773404 |
18 | JAK1 | 1.80965458 |
19 | ZAP70 | 1.71561790 |
20 | GRK6 | 1.67504726 |
21 | MAP2K3 | 1.65322558 |
22 | BCKDK | 1.61221789 |
23 | KIT | 1.55041069 |
24 | CSF1R | 1.53753858 |
25 | LRRK2 | 1.50842189 |
26 | ICK | 1.49150928 |
27 | RIPK1 | 1.44193297 |
28 | KSR2 | 1.40431915 |
29 | TTN | 1.36301122 |
30 | BTK | 1.35770206 |
31 | IKBKE | 1.32182237 |
32 | NEK9 | 1.31074929 |
33 | MARK2 | 1.26637733 |
34 | FLT3 | 1.25763874 |
35 | MAP3K14 | 1.23086473 |
36 | BRD4 | 1.21151447 |
37 | TXK | 1.15588596 |
38 | MAP2K2 | 1.15027823 |
39 | TGFBR2 | 1.12487272 |
40 | BLK | 1.12481740 |
41 | JAK2 | 1.12391225 |
42 | KDR | 1.12126762 |
43 | SYK | 1.11148099 |
44 | FGFR3 | 1.10605009 |
45 | MAPK7 | 1.10512700 |
46 | MAPK11 | 1.10495766 |
47 | MAP3K1 | 1.06480197 |
48 | TAOK2 | 1.06420896 |
49 | TNK2 | 1.03877430 |
50 | CHUK | 1.03492629 |
51 | PRKD2 | 1.02425816 |
52 | PIM1 | 1.01722197 |
53 | CDC42BPA | 1.01215466 |
54 | CDK6 | 1.01209396 |
55 | CDK12 | 0.99661098 |
56 | SIK3 | 0.98568278 |
57 | LMTK2 | 0.97843991 |
58 | CSK | 0.94205598 |
59 | SIK2 | 0.92073473 |
60 | IKBKB | 0.91364009 |
61 | ARAF | 0.90110108 |
62 | ITK | 0.86340322 |
63 | HCK | 0.86325590 |
64 | FGR | 0.84860416 |
65 | RPS6KA4 | 0.81261778 |
66 | MAP3K7 | 0.80367107 |
67 | EPHB1 | 0.80096444 |
68 | SCYL2 | 0.77849467 |
69 | PDGFRA | 0.77807625 |
70 | TAOK1 | 0.77806149 |
71 | CDK4 | 0.76722428 |
72 | IRAK2 | 0.75704610 |
73 | MAP3K9 | 0.74775445 |
74 | PDPK1 | 0.74188417 |
75 | LCK | 0.73121244 |
76 | MAP3K5 | 0.73045413 |
77 | IRAK4 | 0.71440978 |
78 | PIM2 | 0.70354375 |
79 | BMX | 0.70173252 |
80 | MTOR | 0.69975219 |
81 | CAMK1D | 0.69958765 |
82 | PAK4 | 0.66404806 |
83 | MOS | 0.66158656 |
84 | STK4 | 0.66117621 |
85 | MAP3K3 | 0.66113394 |
86 | CAMKK1 | 0.64634496 |
87 | LYN | 0.61909785 |
88 | MATK | 0.61803947 |
89 | MAP3K8 | 0.61162139 |
90 | SGK3 | 0.60496929 |
91 | TGFBR1 | 0.59755779 |
92 | MAP3K13 | 0.59319551 |
93 | PRKCH | 0.58419075 |
94 | PRKD3 | 0.57235723 |
95 | MAPK4 | 0.57010971 |
96 | RAF1 | 0.56302611 |
97 | DYRK1B | 0.56114198 |
98 | CAMK1G | 0.56077781 |
99 | TESK2 | 0.55885910 |
100 | IRAK3 | 0.55198256 |
101 | FES | 0.53344018 |
102 | MAP3K6 | 0.52179576 |
103 | MAP3K11 | 0.50132515 |
104 | NEK2 | 0.49622928 |
105 | HIPK2 | 0.48469684 |
106 | MST1R | 0.47415617 |
107 | PRKCQ | 0.47039321 |
108 | MARK3 | 0.45893100 |
109 | ERBB2 | 0.45786135 |
110 | RPS6KA6 | 0.45423275 |
111 | EPHA3 | 0.44569168 |
112 | TEC | 0.44553359 |
113 | PDGFRB | 0.44538059 |
114 | EGFR | 0.43632388 |
115 | RPS6KA2 | 0.42350585 |
116 | IRAK1 | 0.42151679 |
117 | PDK1 | 0.40783220 |
118 | RPS6KB2 | 0.40596007 |
119 | CDK9 | 0.40449678 |
120 | FRK | 0.40434888 |
121 | TYRO3 | 0.40250100 |
122 | RET | 0.39199318 |
123 | STK3 | 0.38798472 |
124 | RPS6KC1 | 0.38541086 |
125 | RPS6KL1 | 0.38541086 |
126 | MAPKAPK3 | 0.37869037 |
127 | MELK | 0.37714955 |
128 | MAPK12 | 0.37383149 |
129 | MAPK3 | 0.36906562 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.23216094 |
2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.13785475 |
3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.71617459 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.48462681 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.29799292 |
6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.29217807 |
7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.23926018 |
8 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.22778092 |
9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.13732749 |
10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.99809223 |
11 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.78184807 |
12 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.68722983 |
13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.68514258 |
14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.60582063 |
15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.59826964 |
16 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.59460192 |
17 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.53963180 |
18 | Leishmaniasis_Homo sapiens_hsa05140 | 1.48362343 |
19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.47301755 |
20 | Allograft rejection_Homo sapiens_hsa05330 | 1.43887024 |
21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.37953739 |
22 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.37269752 |
23 | Lysine degradation_Homo sapiens_hsa00310 | 1.37164954 |
24 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.37092793 |
25 | Peroxisome_Homo sapiens_hsa04146 | 1.34736878 |
26 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.31117216 |
27 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.30367351 |
28 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.30336929 |
29 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.30040687 |
30 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.28513086 |
31 | ABC transporters_Homo sapiens_hsa02010 | 1.23315620 |
32 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.21600330 |
33 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.18050917 |
34 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.17556956 |
35 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.15296694 |
36 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.13768398 |
37 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.13311327 |
38 | Measles_Homo sapiens_hsa05162 | 1.12675260 |
39 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.11961163 |
40 | Endometrial cancer_Homo sapiens_hsa05213 | 1.10861773 |
41 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.09693846 |
42 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.08722770 |
43 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.07924683 |
44 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.05676050 |
45 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.05478957 |
46 | Carbon metabolism_Homo sapiens_hsa01200 | 1.05101425 |
47 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.04479791 |
48 | Insulin resistance_Homo sapiens_hsa04931 | 1.04127914 |
49 | Bile secretion_Homo sapiens_hsa04976 | 1.00362078 |
50 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.00209620 |
51 | Legionellosis_Homo sapiens_hsa05134 | 0.99873188 |
52 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.99800107 |
53 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.99705807 |
54 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.97975891 |
55 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.97254975 |
56 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.97103627 |
57 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.96838371 |
58 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.96347631 |
59 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.96229003 |
60 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.95860774 |
61 | Bladder cancer_Homo sapiens_hsa05219 | 0.93612938 |
62 | Colorectal cancer_Homo sapiens_hsa05210 | 0.92160921 |
63 | Prion diseases_Homo sapiens_hsa05020 | 0.91653490 |
64 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.90165383 |
65 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.89669191 |
66 | Endocytosis_Homo sapiens_hsa04144 | 0.87294980 |
67 | Glioma_Homo sapiens_hsa05214 | 0.87150749 |
68 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.86834950 |
69 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.86448096 |
70 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.85312156 |
71 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.84897271 |
72 | Apoptosis_Homo sapiens_hsa04210 | 0.84460944 |
73 | HTLV-I infection_Homo sapiens_hsa05166 | 0.83950265 |
74 | Amoebiasis_Homo sapiens_hsa05146 | 0.83119029 |
75 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.82642262 |
76 | Prostate cancer_Homo sapiens_hsa05215 | 0.82518015 |
77 | Sulfur relay system_Homo sapiens_hsa04122 | 0.82225624 |
78 | Asthma_Homo sapiens_hsa05310 | 0.82164095 |
79 | Pertussis_Homo sapiens_hsa05133 | 0.81581998 |
80 | Salmonella infection_Homo sapiens_hsa05132 | 0.81043873 |
81 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.81000140 |
82 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.80091638 |
83 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.79714170 |
84 | Viral myocarditis_Homo sapiens_hsa05416 | 0.78427323 |
85 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.77834476 |
86 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.76335117 |
87 | Influenza A_Homo sapiens_hsa05164 | 0.76266991 |
88 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.76256318 |
89 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.75933336 |
90 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.75274062 |
91 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.74626612 |
92 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.74506275 |
93 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.73771295 |
94 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.73316972 |
95 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.72570658 |
96 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.72410336 |
97 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.72182068 |
98 | Histidine metabolism_Homo sapiens_hsa00340 | 0.72166986 |
99 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.71393661 |
100 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.71383616 |
101 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.70874512 |
102 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.70627620 |
103 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.69621455 |
104 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.69605071 |
105 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.69261052 |
106 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.69199224 |
107 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.68399508 |
108 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.68369284 |
109 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.67803086 |
110 | Focal adhesion_Homo sapiens_hsa04510 | 0.67332055 |
111 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.67156619 |
112 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.66939709 |
113 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.66819447 |
114 | Hepatitis B_Homo sapiens_hsa05161 | 0.66414723 |
115 | Lysosome_Homo sapiens_hsa04142 | 0.66050110 |
116 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.65272718 |
117 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.65023181 |
118 | Tuberculosis_Homo sapiens_hsa05152 | 0.64679007 |
119 | Thyroid cancer_Homo sapiens_hsa05216 | 0.64347297 |
120 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.64031947 |
121 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.63828512 |
122 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.63666709 |
123 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.63529228 |
124 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.63485832 |
125 | Hepatitis C_Homo sapiens_hsa05160 | 0.63310995 |
126 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.63162954 |
127 | Long-term potentiation_Homo sapiens_hsa04720 | 0.63136819 |
128 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.62836705 |
129 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.62479526 |
130 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.62461634 |
131 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.62398964 |
132 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.62243632 |
133 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.62114397 |
134 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.61862179 |
135 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.61691190 |
136 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.61677591 |
137 | Phagosome_Homo sapiens_hsa04145 | 0.59902594 |
138 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.59553090 |
139 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59364317 |
140 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.58208209 |
141 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.58161515 |
142 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.58033815 |
143 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.56998452 |
144 | Retinol metabolism_Homo sapiens_hsa00830 | 0.56705675 |
145 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.56438883 |
146 | Other glycan degradation_Homo sapiens_hsa00511 | 0.55907574 |
147 | Malaria_Homo sapiens_hsa05144 | 0.54982596 |
148 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.53711214 |
149 | Shigellosis_Homo sapiens_hsa05131 | 0.50159558 |
150 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.50066237 |
151 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.49883560 |
152 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.48911244 |
153 | Platelet activation_Homo sapiens_hsa04611 | 0.47655387 |